DE69806098D1 - yerwendung von einer 2-aroyl-3-arylbenzo(b)thiophen Verbindung zur Senkung des Fibrinogens - Google Patents

yerwendung von einer 2-aroyl-3-arylbenzo(b)thiophen Verbindung zur Senkung des Fibrinogens

Info

Publication number
DE69806098D1
DE69806098D1 DE69806098T DE69806098T DE69806098D1 DE 69806098 D1 DE69806098 D1 DE 69806098D1 DE 69806098 T DE69806098 T DE 69806098T DE 69806098 T DE69806098 T DE 69806098T DE 69806098 D1 DE69806098 D1 DE 69806098D1
Authority
DE
Germany
Prior art keywords
aroyl
arylbenzo
thiophene compound
lower fibrinogen
fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69806098T
Other languages
English (en)
Other versions
DE69806098T2 (de
Inventor
Pamela Wang Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69806098D1 publication Critical patent/DE69806098D1/de
Publication of DE69806098T2 publication Critical patent/DE69806098T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69806098T 1997-04-22 1998-04-21 yerwendung von einer 2-aroyl-3-arylbenzo(b)thiophen Verbindung zur Senkung des Fibrinogens Expired - Fee Related DE69806098T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22

Publications (2)

Publication Number Publication Date
DE69806098D1 true DE69806098D1 (de) 2002-07-25
DE69806098T2 DE69806098T2 (de) 2003-01-02

Family

ID=21933208

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69806098T Expired - Fee Related DE69806098T2 (de) 1997-04-22 1998-04-21 yerwendung von einer 2-aroyl-3-arylbenzo(b)thiophen Verbindung zur Senkung des Fibrinogens

Country Status (23)

Country Link
US (1) US6025373A (de)
EP (1) EP0878195B1 (de)
JP (1) JP2001524101A (de)
KR (1) KR20010012084A (de)
CN (1) CN1254255A (de)
AT (1) ATE219364T1 (de)
AU (1) AU741720B2 (de)
BR (1) BR9809286A (de)
CA (1) CA2287196A1 (de)
DE (1) DE69806098T2 (de)
DK (1) DK0878195T3 (de)
EA (1) EA002237B1 (de)
ES (1) ES2178111T3 (de)
HU (1) HUP0002727A3 (de)
ID (1) ID22910A (de)
IL (1) IL132504A0 (de)
NO (1) NO995132L (de)
NZ (1) NZ500389A (de)
PL (1) PL336638A1 (de)
PT (1) PT878195E (de)
TR (1) TR199902605T2 (de)
WO (1) WO1998047365A1 (de)
ZA (1) ZA983298B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
WO1993011704A1 (en) * 1991-12-17 1993-06-24 Eduard Emmanuilovich Godik Method and device for diagnosis of living organism
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
KR950010891A (ko) * 1993-10-15 1995-05-15 피터 지. 스트링거 내성 종양을 치료하는 방법
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
CZ246597A3 (cs) * 1995-02-06 1998-06-17 Eli Lilly And Company Použití sloučeniny k přípravě terapeutického přípravku pro inhibici účinku interleukinu 6, účinků faktoru inhibice leukemie a inhibici systému povrchového receptoru
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
US6025373A (en) 2000-02-15
NO995132D0 (no) 1999-10-21
ES2178111T3 (es) 2002-12-16
CA2287196A1 (en) 1998-10-29
JP2001524101A (ja) 2001-11-27
DK0878195T3 (da) 2002-07-15
IL132504A0 (en) 2001-03-19
KR20010012084A (ko) 2001-02-15
TR199902605T2 (xx) 2000-02-21
WO1998047365A1 (en) 1998-10-29
NZ500389A (en) 2001-07-27
CN1254255A (zh) 2000-05-24
DE69806098T2 (de) 2003-01-02
EP0878195B1 (de) 2002-06-19
MX9909548A (es) 2003-02-27
AU7250398A (en) 1998-11-13
EP0878195A1 (de) 1998-11-18
ZA983298B (en) 1999-10-20
HUP0002727A2 (hu) 2001-08-28
PL336638A1 (en) 2000-07-03
EA199900959A1 (ru) 2000-06-26
ATE219364T1 (de) 2002-07-15
PT878195E (pt) 2002-09-30
HUP0002727A3 (en) 2001-09-28
NO995132L (no) 1999-10-21
EA002237B1 (ru) 2002-02-28
BR9809286A (pt) 2000-07-04
ID22910A (id) 1999-12-16
AU741720B2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
ATE127341T1 (de) Neue verwendung von modafinil.
DE69528730D1 (de) Herstellung von Schwefelenthaltenden Organosiliziumverbindungen
YU79393A (sh) Terapeutska kombinacija
DE68928783D1 (de) Zwischenverbindungen zur Herstellung von Fungiziden
DE69030395D1 (de) Herstellung von Reinigungsmitteln durch Sprühtrocknung
DE69013750D1 (de) Antagonisten von excitatorischen Aminosäuren.
DE69029625D1 (de) Verwendung von Retinoiden zur Umkehr glucocorticoid-induzierter Hautatrophie
DE69323312D1 (de) Herstellung von fluorkohlenwasserstoffen
ATE219364T1 (de) Yerwendung von einer 2-aroyl-3- arylbenzo(b)thiophen verbindung zur senkung des fibrinogens
DE59404861D1 (de) Gewebe zur Verstärkung bzw. Armierung von Flächengebilden
ATE493112T1 (de) Nasensalbe auf basis von vaselin
ATE183201T1 (de) Vielfältig verzweigte peptidkonstruktion zur bekämpfung von hiv
ES2154692T3 (es) Dihidrofarnesal.
ATE267209T1 (de) Reinigung von carboxaldehyd
DE59404066D1 (de) Gewebe zur Verstärkung bzw. Armierung von Flächengebilden
DE59606574D1 (de) Para-Hydroxyphenylessigsäure zur Reduktion der Repellenz von Insektiziden
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
DE69318557D1 (de) Herstellung von fluorkohlenwasserstoffen
FI935901A (fi) Disulfonyylimetaanien käyttö parasiittien kontrollointiin
ATE131172T1 (de) Heterocyclische nmda antagonisten.
IT1312060B1 (it) Uso dell'acido alfa lipoico nel trattamento antimetastatico.
YU2394A (sh) Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida
DE69223253D1 (de) Düngung von bäumen
DK528887A (da) Oscillerende vaeskeudsproejtningsdyse
NO950255D0 (no) Anvendelse av alfa,omega-dikarboksylsyrer som fibrinogenreduserende midler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee